Skip to main content

Table 2 The relationship between BRAFV600E mutation and histopathologic types of DTC

From: Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma

Histopathologictype

Classic type

Aggressive type

 
 

n

%

n

%

P

BRAFV600E

Positive

40

88.9%

15

83.3%

 

BRAFV600E

Negative

5

11.1%

3

16.7%

0.622a

Total

 

45

100%

18

100%

 
  1. a: Fisher’s exact test